Market research on ENT surgical devices is expected to grow with rising prevalence of ENT disorders and preference for minimally invasive surgeries, according to a Dec. 17 news release from Transparency Market Research.
Here are some more key details from the report:
- Notable developments in the global ENT device market include Stryker's acquisition of Entellus Medical, Johnson & Johnson's Acclarent in collaboration with Bioscience Webster and Olympus Corporation's launch of a rhino-laryngo videoscope, all in 2018.
- Other developments include Intersect ENT's FDA approval of a sinus implant in 2017 and Carl Zeiss Meditech AG's launch of devices to improve workflow for ENT procedures in 2018.
- The rise in ENT disorders, especially among children, is expected to be a key driver in the market for devices. This may also lead to more reimbursement support to patients.
- More people are preferring minimally invasive surgeries, which is expected to drive developments in medical technologies.
Read the full release and access the reports here.